EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of the quality of resected thyroid cancer tissue sample on next‐generation sequencing testing

Kanako C Hatanaka, Kenichi Nakamura, Ryohei Katoh, Koichi Ito, Mitsuyoshi Hirokawa, Akira Miyauchi, Yoshihiro Matsuno, Satoshi Kano, Yui Okada, Joji Mori, Yoichi M Ito, Yutaka Hatanaka

Pathology International · 2024

DOI: 10.1111/pin.13399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology International, 2024. Verfasst von Kanako C Hatanaka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: DNA, Neoplasm, Thyroid Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eli Lilly Japan K.K..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activating rearranged during transfection (RET) proto‐oncogene alterations can be identified using next‐generation sequencing (NGS) of tumor DNA/RNA. We assessed factors associated with NGS (Oncomine Dx Target Test [ODxTT]) success for resected thyroid cancer (TC) specimens, including sample age, processing conditions, and DNA/RNA quality. TC samples were from three Japanese hospitals, with sample age

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, NeoplasmThyroid NeoplasmsHumansChildChild, PreschoolFixativesMutationRNAHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

fixativeshigh-throughput DNA/RNA sequencingthyroid neoplasmstissue fixationtissue preservation

Substanzen

FixativesDNA, NeoplasmRNA

Autor:innen und Institutionen

  • Center for Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
  • Japan Drug Development & Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
  • Department of Pathology, Ito Hospital, Tokyo, Japan.
  • Department of Surgery, Ito Hospital, Tokyo, Japan.
  • Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.
  • Department of Surgery, Kuma Hospital, Kobe, Japan.

Förderung

  • Eli Lilly Japan K.K.

Zitieren

APA

Hatanaka, K. C., Nakamura, K., Katoh, R., Ito, K., Hirokawa, M., Miyauchi, A., Matsuno, Y., Kano, S., Okada, Y., Mori, J., Ito, Y. M., & Hatanaka, Y. (2024). Impact of the quality of resected thyroid cancer tissue sample on next‐generation sequencing testing. Pathology International. https://doi.org/10.1111/pin.13399

Vancouver

Hatanaka KC, Nakamura K, Katoh R, Ito K, Hirokawa M, Miyauchi A, et al. Impact of the quality of resected thyroid cancer tissue sample on next‐generation sequencing testing. Pathology International. 2024. doi:10.1111/pin.13399

BibTeX
@article{Hatanaka2024,
  author = {Hatanaka, Kanako C and Nakamura, Kenichi and Katoh, Ryohei and Ito, Koichi and Hirokawa, Mitsuyoshi and Miyauchi, Akira and Matsuno, Yoshihiro and Kano, Satoshi and Okada, Yui and Mori, Joji and Ito, Yoichi M and Hatanaka, Yutaka},
  title = {Impact of the quality of resected thyroid cancer tissue sample on next‐generation sequencing testing},
  journal = {Pathology International},
  year = {2024},
  doi = {10.1111/pin.13399}
}
Kostenlos starten →